Dr. Beth-Anne Sieber joined the NINDS in 2007 as a Program Director in the Neurodegeneration Group. She received her bachelor’s degree in biology and psychology from Rutgers University, after which she received a Ph.D. in Physiology and Neurobiology from a joint program between Rutgers and the University of Medicine and Dentistry of New Jersey. Her graduate studies focused on animal and cell culture models of dopamine neuron development and neurotoxicity, with emphasis on utilizing neuropharmacological and neurochemical approaches to determine the roles of neuronal-glial interactions and neurotrophic factors in these processes. She then pursued postdoctoral studies at the Karolinska Institute in Stockholm, Sweden. While there, she expanded her interest in dopamine neurobiology by utilizing molecular approaches to elucidate the role of neurotrophic factors and receptor tyrosine kinases in cellular and behavioral function in mouse models. Prior to joining the NINDS, Dr. Sieber spent over seven years as a Program Director at the NIMH, where she managed a grant portfolio in developmental neurobiology and co-chaired related efforts for the NIH Neuroscience Blueprint. Her current duties at the NINDS include management of a grants portfolio on Parkinson’s disease, which includes neurobiological approaches to understand neuronal loss and alterations in circuitry, as well as grants in the areas of gene therapy, deep brain stimulation, non-motor aspects of the disease, and Parkinsonian disorders. Dr. Sieber also manages the Udall Centers of Excellence for Parkinson's Disease Research program. She serves as Chair of the Parkinson's Disease Working Group, which coordinates and facilitates research programs and other activities related to Parkinson’s disease within the NINDS.
Active Funding Initiatives for Dr. Sieber
Last Modified May 31, 2013